ライフサイエンスコーパス: SANS

1 SANS (small-angle neutron scattering), SAXS (small-angle

2 SANS also statistically favored TC-5619 (P=0.030).

3 SANS data showed that isopropanol and pyridine both form

4 SANS experiments are consistent with equivalent molecula

5 SANS measurements were performed on homogeneous solution

6 SANS profiles were obtained from 10 degrees C to 55 degr

7 Here we demonstrate a novel concept for a SANS instrument based on axisymmetric focusing mirrors.

8 nique's inception about 40 years ago, as all SANS instruments, save a few, are still designed as pinh

9 ly greater direct effect than placebo on all SANS dimensions except anhedonia-asociality.

10 ril dimensions, as measured by TEM, AFM, and SANS indicate a fibril diameter of 6.4 nm, a height of 6

11 ement with the experimental hydrodynamic and SANS data.

12 ded proteins, by cryo-TEM, LS, DOSY NMR, and SANS studies.

13 gray matter volume for BPRS total score and SANS total score.

14 the virial coefficients measured by SLS and SANS was obtained without use of adjustable parameters.

15 ted by low neuroleptic dose and low baseline SANS total score.

16 Both SANS data and the new computational model, the double su

17 equilibrium methods match those measured by SANS, which also allows reconstruction of the shape of t

18 e nonionic surfactants for CO2 were shown by SANS to be capable of emulsifying up to 20 percent by we

19 ng structures are independently validated by SANS.

20 ith 48-mum pixels, we build the most compact SANS instrument in the world.

21 Neutron scattering models show that the CRP SANS data follow closely the data curve predicted for un

22 f the alpha and beta domains in the ensemble SANS measurements, a likely result of enhanced domain mo

23 are in good agreement with the experimental SANS profiles when the persistence length of the assumed

24 Bilayer thickening was determined from SANS data.

25 Porosity values obtained from SANS are higher than those from two fluid-invasion metho

26 l-Purpose Small-Angle Neutron Scattering (GP-SANS) instrument at Oak Ridge National Laboratory.

27 However, SANS and LPNP methods exhibit a similar pore-size distri

28 e non-native protein conformations; however, SANS is ideally suited to the study of these associated

29 a minimum of 20% reduction from baseline in SANS-18 score.

30 h placebo (group difference, -0.33 change in SANS score per week; 95% CI, -0.62 to -0.05) when genoty

31 nefit with active treatment (-0.59 change in SANS score per week; 95% CI, -0.99 to -0.18).

32 t), mean (95% confidence interval) change in SANS-18 scores was -12.9 (-15.0, -10.8; P<0.0001).

33 e 50-mg dose produced a mean 21% increase in SANS score.

34 eline) were found between placebo and LDX in SANS-18 or PANSS subscale scores.

35 Reductions in SANS scores were also significantly greater with clozapi

36 Contrast variation techniques in SANS enable measurement of the composition of the protei

37 Using contrast variation in SANS measurements, we found that the B808-866 complex is

38 nce comparable to that of conventional large SANS facilities.

39 had significantly higher MMSE scores, lower SANS scores, more years of education, and were younger t

40 he applicability and outlook of microfluidic-SANS for high-throughput and flow processing studies, wi

41 class VII myosin and adaptor proteins: Myo7a/SANS/Harmonin in stereocilia and Myo7b/ANKS4B/Harmonin i

42 le scattering of x-rays (SAXS) and neutrons (SANS) are particularly useful and complementary techniqu

43 improving resolution, paves the way to novel SANS instruments, thus affecting a broad community of sc

44 The analyses of SANS patterns as a function of different solution condit

45 The combination of SANS and modeling clearly enabled us to infer the soluti

46 A combination of SANS, ESI-MS and fluorescence quenching measurements ind

47 However, the basic design of SANS facilities has not changed since the technique's in

48 The clinical findings of SANS have been correlated with structural changes on int

49 A) has documented the variable occurrence of SANS in astronauts returning from long-duration space fl

50 ng with light that, within the resolution of SANS, appears to be completely reversible.

51 Further study of SANS is ongoing for consideration of future manned missi

52 s greater than that for total pores based on SANS results for all four tested samples.

53 l Angle X-ray or Neutron Scattering (SAXS or SANS), it is possible to follow in situ the formation of

54 Further, our SANS measurements indicate that the chlorosome is a lipi

55 of chlorosome particles are suggested in our SANS measurements.

56 Using the low resolution SANS shapes of the protein and lipid core as scaffolding

57 Although several sophisticated SAXS/SANS programs have been developed recently, the impact o

58 on the hydration shell by a systematic SAXS/SANS study using three mutants of a single protein, gree

59 Absolute-scale SANS employing a novel contrast-match-point analysis rev

60 ipoplexes by small-angle neutron scattering (SANS) and by cryogenic transmission electron microscopy

61 ring (SAXS), small angle neutron scattering (SANS) and low-pressure N2 adsorption techniques.

62 Small angle neutron scattering (SANS) and molecular dynamics (MD) simulations were used

63 Small-angle neutron scattering (SANS) and neutron spin echo (NSE) spectroscopy were used

64 we calculate small-angle neutron scattering (SANS) and NSE scattering properties.

65 Small-angle neutron scattering (SANS) and transmission electron microscopy (TEM) confirm

66 ons from the small-angle neutron scattering (SANS) data indicate that both the polyradical with 24 tr

67 s applied to small angle neutron scattering (SANS) data is used to determine the in vitro conformatio

68 attering and small-angle neutron scattering (SANS) data.

69 analysis of small-angle neutron scattering (SANS) data.

70 with recent small angle neutron scattering (SANS) experiments (from 21.4 A at pH 10 to 21.5 A at pH

71 Small-angle neutron scattering (SANS) experiments confirmed its asymmetry and yielded an

72 y performing small-angle neutron scattering (SANS) experiments on isolated triskelia, allowing us to

73 confirmed by small-angle neutron scattering (SANS) experiments on these fluids.

74 Small-angle neutron scattering (SANS) is the most significant neutron technique in terms

75 Small-angle neutron scattering (SANS) is used to confirm the dramatic reduction in micel

76 Small-angle neutron scattering (SANS) is used to probe the solution structure of two pro

77 Small-angle neutron scattering (SANS) measurements show that the phase transition from v

78 Small-angle neutron scattering (SANS) measurements were performed on a solution of singl

79 Small angle neutron scattering (SANS) measurements were performed on solutions of cAMP r

80 Small-angle neutron scattering (SANS) measurements were used to provide detailed informa

81 tch point in small-angle neutron scattering (SANS) measurements.

82 iation using small-angle neutron scattering (SANS) methods.

83 Small angle neutron scattering (SANS) provides the radii of gyration of 1.2-1.8 nm.

84 Small-angle neutron scattering (SANS) revealed a concentration-independent rod-shaped as

85 We performed small-angle neutron scattering (SANS) studies to obtain structural information about the

86 rization and small-angle neutron scattering (SANS) to investigate the changes in membrane structure a

87 Finally, small-angle neutron scattering (SANS) was used to quantify the aggregate dimensions in s

88 MAS) NMR and small-angle neutron scattering (SANS) were consistent with a structural model that invol

89 We applied small angle neutron scattering (SANS) with contrast variation and selective isotopic deu

90 s, including small angle neutron scattering (SANS) with contrast variation, hydrogen-deuterium exchan

91 etermined by small-angle neutron scattering (SANS), a nondestructive technique that did not decrease

92 luorescence, small angle neutron scattering (SANS), and rheological methods.

93 pectroscopy, small-angle neutron scattering (SANS), atomic force microscopy (AFM) based force spectro

94 tegration of small-angle neutron scattering (SANS), low-pressure N2 physisorption (LPNP), and mercury

95 ch combining small-angle neutron scattering (SANS), low-resolution electron microscopy and biophysica

96 ring (SAXS), Small Angle Neutron Scattering (SANS), spectroscopic techniques like NMR and EPR, and ex

97 rimetry, and small-angle neutron scattering (SANS).

98 estigated by small-angle neutron scattering (SANS).

99 ng (SLS) and small-angle neutron scattering (SANS).

100 strated with small-angle neutron scattering (SANS).

101 luidics with small angle neutron scattering (SANS).

102 ymer through small-angle neutron scattering (SANS).

103 of DNA using small-angle neutron scattering (SANS).

104 technique of small-angle neutron scattering (SANS).

105 ation and by small-angle neutron scattering (SANS).

106 ast-matched, small-angle neutron-scattering (SANS) experiments to examine SecA in small unilamellar v

107 Small-angle neutron-scattering (SANS) measurements are used to provide detailed informat

108 Based on in situ SANS results, D s slightly decreases with increasing arg

109 simulation-derived and experimental-solution SANS results are in excellent agreement.

110 ale for the Assessment of Negative Symptoms (SANS) (range, 0-125), Montgomery-Asberg Depression Ratin

111 ale for the Assessment of Negative Symptoms (SANS) and Brief Psychiatric Rating Scale (BPRS) assessed

112 ale for the Assessment of Negative Symptoms (SANS) and several secondary measures were compared.

113 ale for the Assessment of Negative Symptoms (SANS) and the Brief Psychiatric Rating Scale (BPRS) were

114 ale for the assessment of negative symptoms (SANS) and the modified Hamilton rating scale for depress

115 ale for the Assessment of Negative Symptoms (SANS) total scores and change in the average cognitive d

116 ale for the Assessment of Negative Symptoms (SANS) total scores.

117 ale for the Assessment of Negative Symptoms (SANS), among other measures.

118 ale for the Assessment of Negative Symptoms (SANS), the Geriatric Depression Scale and by age.

119 ule for the Assessment of Negative Symptoms (SANS).

120 ; Scale for Assessment of Negative Symptoms (SANS); Clinical Global Impression-Global Improvement (CG

121 ale for the Assessment of Negative Symptoms (SANS); the 50-mg dose produced a mean 21% increase in SA

122 ale for the Assessment of Negative Symptoms (SANS-18) and Positive and Negative Syndrome Scale (PANSS

123 ace flight-associated neuro-ocular syndrome (SANS) has been adopted as an appropriate descriptive ter

124 pneumolysin activates the complement system.SANS data at a variety of neutron contrasts were obtaine

125 The SANS data also demonstrated that the RNA and nucleocapsi

126 The SANS data from the CRP* and cAMP-ligated CRP* are coinci

127 The SANS data indicate that nucleotide turnover can function

128 The SANS data were collected in a number of (1)H:(2)H solven

129 The SANS studies show that the cross-sections of fibers in t

130 The SANS-based in vitro structures indicate that lysozyme tr

131 The SANS-based in vitro structures indicate that under visib

132 There were negative correlations between the SANS total score and rCBF in both the left dorsolateral

133 Furthermore, the SANS data combined with FT-IR spectroscopic analysis of

134 Furthermore, changes in the SANS curves upon DNA binding could be correlated to the

135 f the conformational changes observed in the SANS measurements, and a calorimetric transition enthalp

136 tes a broad transition as is observed in the SANS measurements.

137 no significant differences in change in the SANS total score between glycine and placebo subjects or

138 One site had greater reduction in the SANS total score for patients receiving D-cycloserine re

139 A second site had greater reduction in the SANS total score for placebo patients compared with glyc

140 low solvent ionic strength, analysis of the SANS data shows that the effective PPI for MAb1 is domin

141 Results of the SANS measurements are consistent with the light scatteri

142 Improvement was most notable on the SANS anhedonia and alogia subscales.

143 improvement at the higher DMXB-A dose on the SANS total score and nearly significant improvement on t

144 Shape-reconstruction methods applied to the SANS data indicate that under visible light the protein

145 pe-reconstruction methods are applied to the SANS data to obtain relatively high-resolution conformat

146 random coil shape models were fitted to the SANS measurements at each temperature.

147 tructures that were most consistent with the SANS data revealed that large movements between the thre

148 significantly inversely correlated with the SANS global ratings of negative symptoms.

149 The structural details obtained by TR-SANS should help to delineate the key mechanisms that un

150 -resolved small-angle neutron scattering (TR-SANS), we followed the conformational changes that occur

151 USH1 proteins including myosin VIIa, USH1G (SANS), CIB2 and harmonin.

152 A first attempt at using SANS to directly characterize the thickness and coverage

153 cessible porosity to N2 was determined using SANS and LPNP data.

154 task in noise was negatively correlated with SANS affective flattening score, and hippocampal recruit

155 vide evidence that SEX-LETHAL interacts with SANS-FILLE in the context of the U1 snRNP, through the c

156 ning explicit atomic detergent modeling with SANS measurements has significant potential for structur

157 r effects were replicated in a subgroup with SANS-defined prominent negative symptoms (N = 116) and a